Item 9 Labs Corp (INLB)
0.0001
0.00 (0.00%)
USD |
OTCM |
May 06, 16:00
Item 9 Labs Cash from Operations (TTM): -1.120M for June 30, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
June 30, 2023 | -1.120M |
March 31, 2023 | -3.660M |
December 31, 2022 | -3.321M |
September 30, 2022 | -2.254M |
June 30, 2022 | -1.128M |
March 31, 2022 | -1.136M |
December 31, 2021 | -4.325M |
September 30, 2021 | -5.990M |
June 30, 2021 | -7.048M |
March 31, 2021 | -5.199M |
December 31, 2020 | -2.751M |
September 30, 2020 | -1.141M |
June 30, 2020 | -2.199M |
March 31, 2020 | -1.124M |
December 31, 2019 | -1.892M |
September 30, 2019 | -2.393M |
June 30, 2019 | -1.796M |
March 31, 2019 | -2.610M |
December 31, 2018 | -1.760M |
September 30, 2018 | -0.9758M |
June 30, 2018 | -0.2711M |
March 31, 2018 | 0.004M |
December 31, 2017 | 0.0187M |
Date | Value |
---|---|
September 30, 2017 | 0.0689M |
June 30, 2017 | -0.0838M |
March 31, 2017 | -0.0942M |
December 31, 2016 | -0.2719M |
September 30, 2016 | -0.3397M |
June 30, 2016 | -0.4568M |
March 31, 2016 | -0.6325M |
December 31, 2015 | -0.6021M |
September 30, 2015 | -0.7408M |
June 30, 2015 | -0.7276M |
March 31, 2015 | -0.77M |
December 31, 2014 | -0.7253M |
September 30, 2014 | -0.7386M |
June 30, 2014 | -0.5855M |
March 31, 2014 | -0.5278M |
December 31, 2013 | -0.7264M |
September 30, 2013 | -0.3535M |
June 30, 2013 | -0.5394M |
March 31, 2013 | -0.4744M |
December 31, 2012 | -0.204M |
June 30, 2012 | 0.1556M |
March 31, 2012 | -0.0784M |
December 31, 2011 | -0.0404M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-7.048M
Minimum
Jun 2021
-1.120M
Maximum
Jun 2023
-2.852M
Average
-2.254M
Median
Sep 2022
Cash from Operations (TTM) Benchmarks
Humanigen Inc | -64.32M |
Cantabio Pharmaceuticals Inc | -0.7984M |
Affymax Inc | -- |
RVL Pharmaceuticals PLC | -44.41M |
Scopus BioPharma Inc | -3.043M |